European Commission proposes a change to intellectual property rules to let generic drugmakers enter non-EU markets faster. Patent holders are not happy
In a paper setting out its negotiating terms, the government calls for a far reaching-science and innovation pact and says it will respect the remit of the European Court of Justice
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.